Literature DB >> 19759107

Imaging tumor phenotype: 1 plus 1 is more than 2.

David A Mankoff1, Farrokh Dehdashti.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19759107     DOI： 10.2967/jnumed.108.061044

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  6 in total

1.  Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.

Authors:  Hannah M Linden; Brenda F Kurland; Lanell M Peterson; Erin K Schubert; Julie R Gralow; Jennifer M Specht; Georgiana K Ellis; Thomas J Lawton; Robert B Livingston; Philip H Petra; Jeanne M Link; Kenneth A Krohn; David A Mankoff
Journal:  Clin Cancer Res       Date:  2011-07-12       Impact factor: 12.531

2.  Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.

Authors:  Brenda F Kurland; Lanell M Peterson; Jean H Lee; Hannah M Linden; Erin K Schubert; Lisa K Dunnwald; Jeanne M Link; Kenneth A Krohn; David A Mankoff
Journal:  J Nucl Med       Date:  2011-09-08       Impact factor: 10.057

3.  Oestrogen-related tumour phenotype: positron emission tomography characterisation with ¹⁸F-FDG and ¹⁸F-FES.

Authors:  T Tsujikawa; Y Yoshida; H Maeda; T Tsuchida; T Mori; Y Kiyono; H Kimura; H Okazawa
Journal:  Br J Radiol       Date:  2012-02-14       Impact factor: 3.039

4.  Functional oestrogen receptor α imaging in endometrial carcinoma using 16α-[¹⁸F]fluoro-17β-oestradiol PET.

Authors:  Tetsuya Tsujikawa; Yoshio Yoshida; Yasushi Kiyono; Tetsuji Kurokawa; Takashi Kudo; Yasuhisa Fujibayashi; Fumikazu Kotsuji; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-18       Impact factor: 9.236

5.  Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.

Authors:  Brenda F Kurland; Lanell M Peterson; Jean H Lee; Erin K Schubert; Erin R Currin; Jeanne M Link; Kenneth A Krohn; David A Mankoff; Hannah M Linden
Journal:  Clin Cancer Res       Date:  2016-06-24       Impact factor: 12.531

Review 6.  Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.

Authors:  Clément Bailly; Caroline Bodet-Milin; Mickaël Bourgeois; Sébastien Gouard; Catherine Ansquer; Matthieu Barbaud; Jean-Charles Sébille; Michel Chérel; Françoise Kraeber-Bodéré; Thomas Carlier
Journal:  Cancers (Basel)       Date:  2019-08-31       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.